SYNERGISTIC TUMOR TREATMENT WITH IL-2 AND INTEGRIN-BINDING-FC-FUSION PROTEIN

The present invention provides a method of treating cancer with a combination of IL- 2 and an integrin-binding-Fc fusion protein. The methods of the invention can be applied to a broad range of cancer types. Il est décrit un procédé de traitement du cancer à l'aide d'une combinaison d'...

Full description

Saved in:
Bibliographic Details
Main Authors WITTRUP, KARL DANE, KWAN, BYRON HUA, COCHRAN, JENNIFER R
Format Patent
LanguageEnglish
French
Published 13.02.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a method of treating cancer with a combination of IL- 2 and an integrin-binding-Fc fusion protein. The methods of the invention can be applied to a broad range of cancer types. Il est décrit un procédé de traitement du cancer à l'aide d'une combinaison d'interleukine-2 et d'une protéine de fusion Fc liant l'intégrine. Les procédés selon l'invention peuvent être appliqués à une large gamme de types de cancers.
Bibliography:Application Number: CA20153133162